Bigul

IPCA LABORATORIES LTD. - 524494 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a certified copy of the compliance certificate for the year ended March 31, 2023 under Regulation 40(9) issued by M/s. Parikh Parekh & Associates, practicing Company Secretaries. Kindly acknowledge the receipt of the same.
14-04-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023

Pursuant to the Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 01, 2022 to March 31, 2023 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.
11-04-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

The Company has issued duplicate share certificate(s) to the shareholder in lieu of the original share certificate misplaced / lost as per attached.
06-04-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are enclosing herewith a copy of the Certificate received from Link lntime India Pvt. Ltd., the Registrar and share Transfer Agent of the Company, for the quarter ended March 31, 2023. Kindly acknowledge the receipt of the same.
06-04-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Voting Results Alongwith Scrutinizer Report For Postal Ballot.

We are enclosing herewith the results of the voting on the proposed resolution alongwith the Consolidated Report on the voting issued by Ms. Jigyasa N. Ved of M/s. Parikh & Associates, Practising Company Secretaries, scrutinizer appointed for the said Postal Ballot.
31-03-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Closure of Trading Window

It is hereby notified that the trading window for dealing in the securities of the Company by the insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from close of business hours on 31st March, 2023 and until 48 hours after the declaration of the Company's audited financial results for the 4th quarter and financial year ended 31st March, 2023.
31-03-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached are the details of lost share certificate(s) for which stop transfer has been marked by the Registrar
30-03-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the details of lost share certificate(s) for which stop transfer has been marked by the Registrar:
20-03-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyIPCA LABORATORIES LTD. 2CIN NO.L24239MH1949PLC007837 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 372.44 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Harish P Kamath Designation: Corporate Counsel and Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Ajit Kumar Jain Designation: Joint Managing Director EmailId: [email protected] Date: 06/03/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
06-03-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication regarding dispatch of Postal Ballot Notice and E-voting Details for Postal Ballot
28-02-2023
Next Page
Close

Let's Open Free Demat Account